SEC Form 3 · accession 0001374366-17-000003
Grace Therapeutics, Inc. · GRCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Canan
Director
Period of report
Feb 21, 2017
Accepted (ET)
Feb 22, 2017 · 2:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444192
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Shares (Common Shares) | holding | — | — | — | 5,000 | D | ||
| Class A Shares (Common Shares) | holding | — | — | — | 35,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $2.15 | holding | — | — | — | Feb 21, 2017 | Feb 21, 2022 | Class A Shares (Common Shares) | 17,500 | — | D |